Peramivir+SOC
BCX1812-301
Phase 3 small_molecule terminated
Quick answer
Peramivir+SOC for Cough is a Phase 3 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Indication
- Cough
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated